Catalytic autoantibodies in clinical autoimmunity and modern medicine

Suchkov, 2001, DNA-abzymes and their clinical significance in systemic lupus erythematosis, Ter Arkh, 73, 58 Kozyr, 1998, Novel functional activities of anti-DNA autoantibodies from sera of patients with lymphoproliferative and autoimmune diseases, Appl Biochem Biotechnol, 75, 45, 10.1007/BF02787708 Ponomarenko, 2004, On the catalytic activity of autoantibodies in multiple sclerosis, Dokl Biochem Biophys, 395, 120, 10.1023/B:DOBI.0000025562.98245.13 Suchkov, 2001, DNA-abzymes and cytotoxicity mechanisms in systemic lupus erythematosus, Immunologia, 4, 47 Rose, 2000, Autoantibodies to thyroglobulin in health and disease, Appl Biochem Biotechnol, 83, 245, 10.1385/ABAB:83:1-3:245 Paul, 1995, Natural catalytic antibodies: peptide-hydrolyzing activities of Bence Jones proteins and VL fragment, J Biol Chem, 270, 15257, 10.1074/jbc.270.25.15257 Li, 1995, Catalytic activity of anti-thyroglobulin antibodies, J Immunol, 154, 3328, 10.4049/jimmunol.154.7.3328 Kalinina, 2005, Catalytic autoantibodies in autoimmune myocarditis: clinical and pathogenetic implications, Ter Arkh, 10, 202 Suchkov, 2001, Mechanisms underlying cytotoxicity of anti-DNA antibodies, Bull Exp Biol Med, 131, 475, 10.1023/A:1017936317842 Zhou, 2002, Prospects for immunotherapeutic proteolytic antibodies, J Immunol Methods, 269, 257, 10.1016/S0022-1759(02)00236-3 Lacroix-Desmazes, 2005, High levels of catalytic antibodies correlate with favorable outcome in sepsis, Proc Natl Acad Sci U S A, 102, 231, 10.1073/pnas.0500586102 Naumova, 2003, DNA-abzymes in autoimmune pathology in clinics and experiment, Nauchno-Prakticheskaya Revmatologiya, 1, 11 Andrievskaya, 2002, Catalytic diversity of polyclonal RNA-hydrolyzing IgG antibodies from the sera of patients with systemic lupus erythematosus, Immunol Lett, 81, 191, 10.1016/S0165-2478(02)00006-8 Baranovsky, 1997, DNA- and RNA-hydrolyzing antibodies from the blood of patients with various forms of viral hepatitis, Biochemistry (Mosc), 62, 1590 Rekvig, 2004, Anti-DNA antibody subpopulations and lupus nephritis, Autoimmun Rev, 3, 1, 10.1016/S1568-9972(03)00081-8 Nezlin, 1998, Immunochemical determination of DNA in immune complexes present in the circulation of patients with systemic lupus erythematosus, J Autoimmun, 11, 489, 10.1006/jaut.1998.0231 Pisetsky, 2001, Immune response to DNA in systemic lupus erythematosus, Isr Med Assoc J, 3, 850 Raz, 1993, Cross-reactions of anti-DNA autoantibodies with cell surface proteins, Eur J Immunol, 23, 383, 10.1002/eji.1830230213 Misikov, 2005, Catalytic autoantibodies in multiple sclerosis: pathogenetic and clinical aspects, Bull Exp Biol Med, 139, 85, 10.1007/s10517-005-0220-7 Sinohara, 2000, Does catalytic activity of Bence-Jones proteins contribute to the pathogenesis of multiple myeloma?, Appl Biochem Biotechnol, 83, 85, 10.1385/ABAB:83:1-3:85 Wilkinson, 2001, Antibody-dependent cell-mediated cytotoxicity: a flow cytometry-based assay using fluorophores, J Immunol Methods, 258, 183, 10.1016/S0022-1759(01)00474-4 Fishelson, 2001, Complement and apoptosis, Mol Immunol, 38, 207, 10.1016/S0161-5890(01)00055-4 Ponomarenko, 2000, Natural antibody catalytic activities in mice with autoimmune disorders, Dokl Biochem, 375, 224, 10.1023/A:1026619805983 Grootscholten, 2003, Deposition of nucleosomal antigens (histones and DNA) in the epidermal basement membrane in human lupus nephritis, Arthritis Rheum, 48, 1355, 10.1002/art.10974 Dubrovskaya, 2003, DNA-hydrolyzing antibodies from sera of autoimmune-prone MRL/MpJ-lpr mice, Biochemistry (Mosc), 68, 1323, 10.1023/A:1026350426842 Kotzin, 2001, Anti-DNA meets NMDA in neuropsychiatric lupus, Nat Med, 7, 1175, 10.1038/nm1101-1175 Reichlin, 1998, Cellular dysfunction induced by penetration of autoantibodies into living cells: cellular damage and dysfunction mediated by antibodies to dsDNA and ribosomal P proteins, J Autoimmun, 11, 557, 10.1006/jaut.1998.0219 Amoura, 2000, The role of nucleosomes in lupus, Curr Opin Rheumatol, 12, 369, 10.1097/00002281-200009000-00003 Carroll, 2001, Innate immunity in the etiopathology of autoimmunity, Nat Immunol, 2, 1089, 10.1038/ni1201-1089 Gao, 1997, Making chemistry selectable by linking it to infectivity, Proc Natl Acad Sci U S A, 94, 11777, 10.1073/pnas.94.22.11777 Buneva, 1998, Catalytic DNA- and RNA-hydrolyzing antibodies from milk of healthy human mothers, Appl Biochem Biotechnol, 75, 63, 10.1007/BF02787709 Suchkov, 2003, Protabzymes and their future in medicine and biotechnology, Meditsinskaya Immunologiya, 5, 272 Pillet, 2002, Idiotypic network mimicry and antibody catalysis: lessons for the elicitation of efficient anti-idiotypic protease antibodies, J Immunol Methods, 269, 5, 10.1016/S0022-1759(02)00221-1 Jones, 2001, The therapeutic potential for catalytic antibodies: from a concept to a promise, Mini Rev Med Chem, 1, 125, 10.2174/1389557013407070 Haney, 2004, Therapeutic vaccines for substance dependence, Expert Rev Vaccines, 3, 11, 10.1586/14760584.3.1.11 Rader, 2003, A humanized aldolase antibody for selective chemotherapy and adaptor immunotherapy, J Mol Biol, 332, 889, 10.1016/S0022-2836(03)00992-6 Jones, 2001, Conversion of enediynes into quinones by antibody catalysis and in aqueous buffers: implications for an alternative enediyne therapeutic mechanism, J Am Chem Soc, 123, 3607, 10.1021/ja005864z Hafler, 2004, Multiple sclerosis, J Clin Invest, 113, 788, 10.1172/JCI21357 Amital, 1995, Catalytic antibodies. Structure and possible applications, Methods Mol Biol, 51, 203